Bio­gen vet Jean-Paul Kress takes the reins at NY­C's Syn­tim­mune

New York City start­up Syn­tim­mune has re­cruit­ed Bio­gen’s for­mer head of glob­al op­er­a­tions Jean-Paul Kress, to lead the com­pa­ny as pres­i­dent and CEO.

Kress is tak­ing over the top job from David de Graaf, who’s been CEO since mid-2016 but who is now re­sign­ing from his po­si­tion and the com­pa­ny’s board. Kress had a rel­a­tive­ly short stint at Bio­gen, where he worked as ex­ec­u­tive vice pres­i­dent, pres­i­dent in­ter­na­tion­al, and head of glob­al ther­a­peu­tic op­er­a­tions from June 2017 un­til now. Be­fore that, he was at Sanofi Gen­zyme as vice pres­i­dent and head of North Amer­i­ca, where he played a key role in launch­ing dupilum­ab, among oth­er prod­ucts.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER